5 completed, 1 terminated, 1 unknown. 7 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 5, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Head and Neck Neoplasm: new trials by email Literature Review of Head and Neck Neoplasm trials Research Report on Head and Neck Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results GH21 Capsule - Advanced Solid Tumor, Non-Small Cell Lung Cancer | Phase 1 | Unknown | Suzhou Genhouse Bio Co., Ltd. | 68 | 2022-02-20 | 2024-07-16 |
| Dose-Escalated Hypofractionated Adaptive Radiotherapy for Head and Neck Cancer 50 Gy Radiation Therapy, 55 Gy Radiation Therapy, 60 Gy Radiation Therapy - Head and Neck Neoplasm | Phase 1 | Completed | Medical College of Wisconsin | 18 | 2021-01-26 | 2026-09-21 |
| A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer Patients SZKJT(San-Zhong-Kui-Jian-Tang) - Head and Neck Neoplasm, Chemoradiotherapy | Phase 1 | Completed | China Medical University Hospital | 21 | 2018-07-07 | 2022-10-26 |
| HARE-40: HPV Anti-CD40 RNA vaccinE BNT113 - Human Papilloma Virus Related Carcinoma, Head and Neck Neoplasm | Phase 1 / Phase 2 | Completed | University of Southampton | 30 | 2017-04-11 | 2026-10-07 |
| 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients 131I-Tenatumomab - Breast Neoplasm, Head and Neck Neoplasm | Phase 1 | Terminated | sigma-tau i.f.r. S.p.A. | 2 | 2015-11-01 | 2018-09-18 |
| Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms PF00562271 - Head and Neck Neoplasm, Prostatic Neoplasm | Phase 1 | Completed | Verastem, Inc. | 99 | 2005-12-01 | 2013-03-21 |
| A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer paclitaxel concurrent with radiation therapy - Head and Neck Neoplasm, Squamous Cell Carcinoma | Phase 1 | Completed | National Cancer Institute (NCI) | 35 | 1995-07-01 | 2008-03-04 |
Head and Neck Neoplasms (7) · Pancreatic Neoplasms (3) · Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Squamous Cell (1) · Colorectal Neoplasms (1) · Digestive System Neoplasms (1) · Lymphoma, Non-Hodgkin (1) · Neoplasms (1) · Neoplasms, Connective and Soft Tissue (1) · Neoplasms, Unknown Primary (1) · Penile Neoplasms (1) · Prostatic Neoplasms (1) · Respiratory Tract Neoplasms (1) · Skin Neoplasms (1)
Neoplasms by Site (7) · Neoplasms (6) · Digestive System Diseases (3) · Endocrine Gland Neoplasms (3) · Endocrine System Diseases (3) · Male Urogenital Diseases (3) · Pancreatic Diseases (3) · Urogenital Diseases (3) · Digestive System Neoplasms (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Male (2) · Genital Neoplasms, Male (2) · Neoplasms by Histologic Type (2)
PF-00562271 (1) · Radiotherapy (1) · atezolizumab (1)
China Medical University Hospital (1) · Medical College of Wisconsin (1) · National Cancer Institute (NCI) (1) · Suzhou Genhouse Bio Co., Ltd. (1) · University of Southampton (1) · Verastem, Inc. (1) · sigma-tau i.f.r. S.p.A. (1)
United States (3) · Australia (1) · Canada (1) · China (1) · France (1) · Italy (1) · Taiwan (1) · United Kingdom (1)
Christian Ottensmeier, Prof (1) · Haidan Wang, Doctorate (1) · Ioannis Karydis, Dr (1) · Ming-Yu Lien, Ph.D (1) · Musaddiq Awan, MD (1)
2014 (2), R21CA256144 (1)